A medicine made from the marijuana plant moved one step closer to U.S. approval for the treatment of severe seizures in children with epilepsy

 A medicine made from the marijuana plant moved one step closer to U.S. approval Thursday after federal health advisers endorsed it for the treatment of severe seizures in children with epilepsy.

Accordingly, the GW Pharmaceuticals' syrup would become the first drug derived from the cannabis plant to win federal approval in the U.S. if the Food and Drug Administration follows the group's recommendation.

The 13-member FDA panel voted unanimously in favor of the experimental medication made from a chemical found in cannabis — one that does not get users high. The panelists backed the drug based on three studies showing that it significantly reduced seizures in children with two rare forms of childhood epilepsy.

"This is clearly a breakthrough drug for an awful disease," said panel member Dr. John Mendelson, of the Friends Research Institute in Baltimore, Maryland.

The drug made from marijuana carries a potential risk of liver damage, but panelists said doctors could monitor patients for any signs. Other common side effects included diarrhea, vomiting, fatigue and sleep problems.

• Diabetes Neuropathy: Symptoms, Causes and Treatmen...
• 20 Home Remedies For Cough
• 3 REASONS WHY NUTS MIGHT BE GOOD FOR DIABETES
• Patients less satisfied by GPs who refuse antibiot...
• Tumeric Helps To Control Diabetes
• 7 Risk Factors Shared By Diabetes And Certain Canc...
• 10 STEPS TO BETTER DIABETES DIET
• Remaining deer at Winona County farm found to have...